Added to YB: 2022-11-30
Pitch date: 2022-11-30
OABI [bullish]
OmniAb, Inc.
-40.28%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
Market Cap
$224.6M
Pitch Price
$3.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.37
P/E
-2.64
EV/Sales
8.82
Sector
Life Sciences Tools and Services
Category
N/A
Show full summary:
OMNIAB INC OABI
A summary for this pitch has not been created yet.
Read full article (0 min)